These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9643844)

  • 41. The Lyme vaccine: a cautionary tale.
    McSweegan E
    Epidemiol Infect; 2007 Jan; 135(1):9-10. PubMed ID: 17064458
    [No Abstract]   [Full Text] [Related]  

  • 42. Progress and controversy surrounding vaccines against Lyme disease.
    Hanson MS; Edelman R
    Expert Rev Vaccines; 2003 Oct; 2(5):683-703. PubMed ID: 14711329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth-inhibiting antibody responses of humans vaccinated with recombinant outer surface protein A or infected with Borrelia burgdorferi or both.
    Luke CJ; Marshall MA; Zahradnik JM; Bybel M; Menefee BE; Barbour AG
    J Infect Dis; 2000 Mar; 181(3):1062-8. PubMed ID: 10720532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective immunity elicited by rBCG vaccines.
    Stover CK; Bansal GP; Langerman S; Hanson MS
    Dev Biol Stand; 1994; 82():163-70. PubMed ID: 7958471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
    Eschner AK; Mugnai K
    Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine.
    Keller D; Koster FT; Marks DH; Hosbach P; Erdile LF; Mays JP
    JAMA; 1994 Jun; 271(22):1764-8. PubMed ID: 8196120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment and prevention of Lyme disease, with emphasis on antimicrobial therapy for neuroborreliosis and vaccination.
    Wormser GP
    Semin Neurol; 1997 Mar; 17(1):45-52. PubMed ID: 9166959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunization in Lyme borreliosis--initial experience].
    Bartůnĕk P; Mrázek V
    Cas Lek Cesk; 1999 May; 138(11):340-2. PubMed ID: 10422346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Need for a New Lyme Disease Vaccine.
    Plotkin SA
    N Engl J Med; 2016 Sep; 375(10):911-3. PubMed ID: 27602662
    [No Abstract]   [Full Text] [Related]  

  • 50. Biting back at Lyme disease.
    Travis J
    Science; 1992 Jun; 256(5064):1623. PubMed ID: 1609273
    [No Abstract]   [Full Text] [Related]  

  • 51. The new vaccine for Lyme disease.
    Rusk M; Gluckman S
    Hosp Pract (1995); 1999 Aug; 34(8):37-9. PubMed ID: 10459362
    [No Abstract]   [Full Text] [Related]  

  • 52. Disarming Lyme disease.
    Kantor FS
    Sci Am; 1994 Sep; 271(3):34-9. PubMed ID: 8091189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis of an experimental glycolipoprotein vaccine against Lyme disease.
    Pozsgay V; Kubler-Kielb J
    Carbohydr Res; 2007 Feb; 342(3-4):621-6. PubMed ID: 17182019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A vaccine against Lyme disease?
    Wormser GP
    Ann Intern Med; 1995 Oct; 123(8):627-9. PubMed ID: 7677306
    [No Abstract]   [Full Text] [Related]  

  • 55. Lyme disease vaccine: good for dogs, adults, and children?
    Feder HM
    Pediatrics; 2000 Jun; 105(6):1333-4. PubMed ID: 10835077
    [No Abstract]   [Full Text] [Related]  

  • 56. Lyme disease: geography predicts risk.
    Grabenstein JD
    J Am Pharm Assoc (Wash); 1999; 39(1):86-91. PubMed ID: 9990193
    [No Abstract]   [Full Text] [Related]  

  • 57. The Sixth International Conference on Lyme Borreliosis: progress on the development of Lyme disease vaccines. 19-22 June 1994, Bologna, Italy.
    Edelman R
    Vaccine; 1995 Jan; 13(1):133-5. PubMed ID: 7762271
    [No Abstract]   [Full Text] [Related]  

  • 58. Occupational risk of Lyme disease: an epidemiological review.
    Piacentino JD; Schwartz BS
    Occup Environ Med; 2002 Feb; 59(2):75-84. PubMed ID: 11850549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guarded endorsement for Lyme disease vaccine.
    Marwick C
    JAMA; 1998 Jun; 279(24):1937-8. PubMed ID: 9643844
    [No Abstract]   [Full Text] [Related]  

  • 60. Lyme disease vaccine given guarded approval in the US.
    Rutter T
    BMJ; 1998 Jun; 316(7146):1695. PubMed ID: 9652919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.